Lu, Youtao http://orcid.org/0000-0002-7822-2784
Lee, Jaehee http://orcid.org/0000-0002-8247-0967
Li, Jifen http://orcid.org/0000-0001-8626-7707
Allu, Srinivasa Rao http://orcid.org/0000-0002-6530-2582
Wang, Jinhui
Kim, HyunBum
Bullaughey, Kevin L.
Fisher, Stephen A.
Nordgren, C. Erik
Rosario, Jean G.
Anderson, Stewart A.
Ulyanova, Alexandra V. http://orcid.org/0000-0002-1319-5279
Brem, Steven
Chen, H. Isaac
Wolf, John A.
Grady, M. Sean
Vinogradov, Sergei A.
Kim, Junhyong http://orcid.org/0000-0002-7726-8246
Eberwine, James
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG010023)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (DP1AA028409)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01MH098953, R01MH110185)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 30 May 2023
Accepted: 2 November 2023
First Online: 14 November 2023
Competing interests
: The Authors declare the following competing interests. J.E., J.Y.K., Y.L., S.F., J. Li, are co-inventors on a published patent application (20200216841) covering the CHEX-seq technology applied for by the University of Pennsylvania and Agilent Technologies. J.E., Y.L., J.Y.K., S.R.A., S.V. are co-inventors on a provisional patent application (63/511,984) covering gDNAzymes applied for by the University of Pennsylvania. The remaining authors declare no competing interests. This work was funded in part by NIH U01MH098953 (J.E., J.K.) and RM1HG010023 (J.K., J.E.), and by R01MH110185 (S.A).